FlawCheck Citator
Check how courts have cited this case. Use our free citator for the most current treatment.
No. 10793861
United States Court of Appeals for the Ninth Circuit

Kagan v. Bisignano

No. 10793861 · Decided February 13, 2026
No. 10793861 · Ninth Circuit · 2026 · FlawFinder last updated this page Apr. 2, 2026
Case Details
Court
United States Court of Appeals for the Ninth Circuit
Decided
February 13, 2026
Citation
No. 10793861
Disposition
See opinion text.
Full Opinion
NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS FEB 13 2026 MOLLY C. DWYER, CLERK U.S. COURT OF APPEALS FOR THE NINTH CIRCUIT VICTOR KAGAN, No. 24-7023 D.C. No. Plaintiff - Appellant, 4:23-cv-04886-KAW v. MEMORANDUM* FRANK BISIGNANO, Commissioner of Social Security, Defendant - Appellee. Appeal from the United States District Court for the Northern District of California Kandis A. Westmore, Magistrate Judge, Presiding Submitted February 11, 2026** San Francisco, California Before: N.R. SMITH, NGUYEN, and SANCHEZ, Circuit Judges. Claimant Victor Kagan appeals the district court’s decision affirming the Commissioner of Social Security’s denial of his application for disability insurance benefits under Title II of the Social Security Act. We have jurisdiction under 28 * This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3. ** The panel unanimously concludes this case is suitable for decision without oral argument. See Fed. R. App. P. 34(a)(2). U.S.C. § 1291. We affirm. The administrative law judge (“ALJ”) did not err in weighing the medical opinions of Kagan’s examining psychologists. The new framework, 20 C.F.R. § 404.1520c (a), (c), eliminated the hierarchy of medical opinions that prioritized the views of treating physicians, and instead requires the ALJ to evaluate the persuasiveness of all medical opinions primarily on the basis of supportability and consistency. See Woods v. Kijakazi, 32 F.4th 785, 791 (9th Cir. 2022). The ALJ’s decision is consistent with the new framework. The ALJ evaluated each medical opinion’s persuasiveness based on the extent to which it was supported by objective medical findings and its consistency with the evidence in the record, and the ALJ’s conclusions are supported by substantial evidence. Id. at 791-92. The ALJ also did not err in discounting Kagan’s testimony. See Smith v. Kijakazi, 14 F.4th 1108, 1111-1112 (9th Cir. 2021). The ALJ explained how the evidence conflicted with Kagan’s testimony on the intensity, persistence, and limiting effects of his symptoms. This evidence included Kagan’s daily life activities, prior inconsistent statements, and objective medical evidence that showed less severe findings. See Smartt v. Kijakazi, 53 F.4th 489, 498 (9th Cir. 2022) (“When objective medical evidence in the record is inconsistent with the claimant’s subjective testimony, the ALJ may indeed weigh it as undercutting such testimony.”); see also Rounds v. Comm’r Soc. Sec. Admin., 807 F.3d 996, 1006 (9th 2 24-7023 Cir. 2015) (“To assess a claimant’s credibility, the ALJ may consider . . . ‘ordinary techniques of credibility evaluation,’ ‘inadequately explained failure to seek treatment or to follow a prescribed course of treatment,’ and ‘the claimant’s daily activities.’” (citation omitted)). Accordingly, the ALJ supported his decision to discount Kagan’s subjective testimony with specific, clear, and convincing reasons. Because the Commissioner’s decision is not based on legal error and is supported by substantial evidence, we will not overturn it. See 42 U.S.C. § 405(g); Kitchen v. Kijakazi, 82 F.4th 732, 738 (9th Cir. 2023). AFFIRMED. 3 24-7023
Plain English Summary
NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS FEB 13 2026 MOLLY C.
Key Points
Frequently Asked Questions
NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS FEB 13 2026 MOLLY C.
FlawCheck shows no negative treatment for Kagan v. Bisignano in the current circuit citation data.
This case was decided on February 13, 2026.
Use the citation No. 10793861 and verify it against the official reporter before filing.
Why Attorneys Choose FlawFinder

Why Attorneys Choose FlawFinder

Side-by-side with Westlaw and LexisNexis

Feature FlawFinder Westlaw LexisNexis
Monthly price$19 – $99$133 – $646$153 – $399
ContractNone1–3 year min1–6 year min
Hidden fees$0, alwaysUp to $469/search$25/mo + per-doc
FlawCheck citatorIncludedKeyCite ($$$)Shepard's ($$$)
Plain-English summaryIncludedNoNo
CancelOne clickTermination feesAccount friction
Related Cases

Full legal research for $19/month

All 50 states · Federal regulations · Case law · Police SOPs · AI analysis included · No contract

Continue Researching →